San Raffaele Hospital — Clinical Trial Site

35 Registered trials

17 Currently recruiting

Organisation

San Raffaele Hospital

Location

Milan, Italy

Identifier

ORG-100029986

Address

Via Olgettina 58, 20132, Italy

Departments

Anestesia e Rianimazione del distretto testa-collo
Arrhythmology and Electrophysiology
cardiology
Centro Scienze Natalità
Colorectal surgery Unit
Department Gastroenterology and Digestive Endoscopy
Department of Oncology
Ginecologia Ostetricia
Gynecology and Obstetrics Department
Infectious Diseases
Medical Oncology
Medicine and Diabetes Unit
Metabolic and Clinical Trial Unit
Neurology
Neuromuscular Repair Unit
Oncologia Medica
Oncology
Orthopaedic and Trauma Unit
Paediatric hematology & Oncology
Paediatrics
Pediatric Immunohematology Unit
Radiotherapy Unit
Strategic Research Program on Chronic Lymphocytic Leukemia, Division of Experimental Oncology
Strategic Research Program on CLL
U.O. Immunoematologia Pediatrica
U.O. Pediatric Immunohematology
Unit of Infectious Diseases
Unità Operativa di Oculistica
UO Oncologia
UOC Oncologia

Clinical trials at this site (35)

Search interface

A prospective, observer-blind, randomized clinical trial to investigate and compare the clinical efficacy of Chloroprocaine 3% gel and Oxybu… Not authorised

2023-504477-21-00 male/female outpatients, aged 0-17 years scheduled to u 5
Efficacy of peri-operative dexamethasone administration in single bundle anterior cruciate ligament reconstruction: a prospective randomized… Not authorised

2024-511559-17-00 Adult patients with indication of arthroscopic anterior 6
A randomized phase II study of Pembrolizumab (MK-3475) as maintainance therapy in patients with unresectable stage III non-small cell lung … Pending

2024-514701-57-01 non Small Cell Lung Cancer 4
A phase I/II open label study to assess safety, feasibility and efficacy of ex vivo expanded, autologous haematopoietic stem and progenitor … Pending

2024-518972-30-00 Autosomal recessive osteopetrosis caused by mutations i 7
Hyperprogression upon cemiplimab alone or with chemotherapy in PD-L1 ≥ 50% NSCLC: a biomarker guided phase 2 trial – HYPERBOLIC study Pending

2025-521583-35-00 non-small cell lung cancer (NSCLC) 4
A single arm, open label, multicenter, single-dose, phase 2b clinical study evaluating efficacy and safety of gene therapy using autologous … Pending

2025-522160-32-00 transfusion-dependent beta-thalassemia 4
An Open Label, Single Arm, Phase I/II Clinical Study of Autologous CD4+ T-Cells Edited Ex-Vivo at the CD40LG Locus by CRISPR/Cas9 and IDLV-b… Pending

2025-524635-39-00 X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) 7
Trial of T-DXd Versus SoC Chemotherapy as Adjuvant Treatment in Endometrial Cancer Recruiting

2024-519444-33-00 HER2-expressing endometrial cancer (IHC 3+/2+) 5 2026-03-12
A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy. Recruiting

2025-522553-19-00 Symptomatic genetic and familial dilated cardiomyopathy 10 2026-02-25
A Phase 2 Clinical Trial to Investigate Safety, Tolerability and Efficacy of TransCon CNP, Weekly Subcutaneous Injections, Compared with Pla… Recruiting

2023-506091-27-00 Achondroplasia in Children and Adolescents 4 2024-09-19
A Long-term Follow-up Study for Subjects Previously Treated with Autologous ex vivo Lentiviral Hematopoietic Stem and Progenitor Cell Gene T… Recruiting

2024-518369-92-00 Wiskott-Aldrich syndrome (WAS) 5 2025-06-25
A Phase 3 Study Comparing BMS-986365 versus Investigator’s Choice of Therapy in Participants with Metastatic Castration-resistant Prostate C… Recruiting

2024-517422-25-00 Metastatic Castration-resistant Prostate Cancer (mCRPC) 5 2025-05-22
A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping t… Recruiting

2024-517584-23-00 Duchenne Muscular Dystrophy 9 2025-05-16
Myocarditis Therapy with Steroids in patients with a Mildly Reduced ejection fraction (MYTHS-MR) Recruiting

2022-501547-33-01 Acute myocarditis 11 2024-12-24
A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 2 trial to evaluate the efficacy and safety of BP1.7881 in… Recruiting

2023-508949-40-00 Eosinophilic esophagitis 4 2024-11-29
A Phase II Multicentric Study of Olaparib in PALB2-related Advanced Pancreatic Cancer (PALBOLA) Recruiting

2024-516466-11-00 Locally advanced or metastatic pancreatic neoplasm with 4 2024-11-12
Extended LH administration (ELHA), a strategy to increase the pool of recruitable antral follicles: a multicentric randomized trial Recruiting

2024-517407-36-00 Patients admitted to an IVF/ICSI cycle will be included 4 2024-11-12
A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects with WAS. Recruiting

2024-517792-20-00 Wiskott-Aldrich Syndrome 5 2024-10-29
Sbrt±sTad for Unfavorable iNtermediate rIsk/high-risk prostate cancer (STUNNIN): A Randomized Phase II Study Recruiting

2024-511886-12-00 Unfavorable intermediate/high risk prostate cancer pati 4 2024-04-29
A multicenter single-arm phase II interventional study to evaluate the activity and safety of the combination of Platinum-Pemetrexed based c… Recruiting

2023-506714-43-00 ALK positive Non-Small Cell Lung Cancer 4 2024-03-15
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies Recruiting

2023-510541-25-00 Relapsed/Refractory B-cell Malignancies 1 2023-10-09
Temozolomide and irinotecan consolidation in patients with MGMT silenced, microsatellite stable colorectal cancer with persistence of minima… Recruiting

2024-515681-14-00 Stage II (pT4)/III colorectal cancer with positive circ 4 2022-05-02
FI-3, Fidelia Recruiting

2024-518243-38-00 Fecal incontinence in female and male patients 5 2022-04-20
Clinical trial to evaluate safety and effectiveness of APL-101 for the treatment of advanced MET expressing solid tumors, including Non-Smal… Recruiting

2024-514542-37-00 Select advanced solid tumors and Non-Small Cell Lung Ca 9 2020-08-13